Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer.
about
Responsiveness of quality of life instruments for the comparison of minimally invasive cholecystectomy proceduresAssessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study.A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials.Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumorsFactors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.PROMIS for Laparoscopy.Joint modeling of multiple longitudinal patient-reported outcomes and survivalPlanning and reporting of quality-of-life outcomes in cancer trials.Differential dropout and bias in randomised controlled trials: when it matters and when it may not.Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients.Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer.Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation--A preliminary report.New challenges for comparative effectiveness in oncology: choice of primary end points for randomized clinical trials.Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†.Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension.Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions.Power and sample size determination in the Rasch model: evaluation of the robustness of a numerical method to non-normality of the latent trait.Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients.The use and reporting of patient-reported outcomes in phase III breast cancer trials.Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).Towards power and sample size calculations for the comparison of two groups of patients with item response theory models.A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need?Trends in endpoint selection in clinical trials of advanced breast cancer.A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancerThe importance of patient-reported outcomes in clinical trials and strategies for future optimization
P2860
Q26828800-A34352B4-9555-462B-B703-526585FA27ABQ30837515-DCAE9208-5267-4A5B-ADE1-010FB2ACE84BQ31030585-C46A3996-8AB9-4654-B8DE-812F8D8A506BQ33807103-D75DAF6D-564A-4670-AB0D-3754CFDB8225Q34052479-D4CD9146-EC05-4168-AAFA-DBB66FEFDFB5Q34416642-542A26ED-C12F-464E-A406-91DB66FFFB44Q34666843-70FD9A1B-9FD3-46F9-832E-A8A2D47B9562Q35514712-721EA718-E916-4040-86DB-24D99CFBF477Q35540770-C060624F-F96C-48A8-A8BA-2D25A26D5210Q36000225-4A27DA9C-E9DB-4D12-AAAC-4E8CB4B1E1B9Q36396594-658EF85F-22C2-47FE-AF5A-CE8EAF812628Q37491264-E88A32BA-570E-4C72-8963-BC203B334857Q37594615-BE868B75-5419-4757-8A4F-B978777F8B5CQ37756336-040432F2-F34A-4CCF-B98A-D9FB8F2F78EEQ37812571-C33B8853-3FFF-49A7-A9B2-ED3287360E48Q37827010-F66F27A0-2DBC-46B5-B673-BFA8D5F01BDBQ38044290-6A0D7AD2-C6F7-4B01-B9B3-31568A396E8EQ38158607-5165C7F8-F1D2-44FA-B52F-77A04287BFBDQ38162911-55970E77-AC7C-426A-8208-069767AD99A1Q38447986-A216E0AC-B265-4078-A438-991396D9C52CQ38872226-F457012A-9DF8-4E44-AAA4-1A819F5B3725Q38880129-FB3D9C57-5327-40AB-A90D-32D088D70CBBQ38974921-A4D13BBB-E822-4838-A035-683A5681C165Q39192789-9DB48B1F-1F1A-4C01-B70C-217BD4EBCCA7Q41849264-C6F387EB-0F41-4D57-B7C8-860857E56E17Q45239859-2AABB46C-59A6-4E0C-8ECD-C29E9FEBE521Q46266472-CEE288BE-EE8B-4F04-854A-E7E9CBD928DEQ46859743-128830B2-75BB-4D1F-8306-4C39347F04EFQ47345068-158B1FE8-088D-44A6-AFAE-2EC64B7668A7Q47629735-4E8C0FAE-3804-4376-9ECC-8E3AF761136AQ48849283-23CB617E-EC45-42B6-9937-D19357D38168Q50160426-3D4655B3-5D82-4C18-A65F-91AB69425B34Q57164771-193156E0-4BF2-4011-92C1-3226FA6AB1D1Q59135171-7959D3A7-7F0E-49F4-A023-46BFF2F65744
P2860
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Quality of life and/or symptom ...... patients with advanced cancer.
@en
type
label
Quality of life and/or symptom ...... patients with advanced cancer.
@en
prefLabel
Quality of life and/or symptom ...... patients with advanced cancer.
@en
P2093
P356
P1433
P1476
Quality of life and/or symptom ...... patients with advanced cancer.
@en
P2093
P304
P356
10.1093/ANNONC/MDM121
P577
2007-08-13T00:00:00Z